Predictiv
Signal active
Organization
Contact Information
Overview
Predictiv is the first DNA-base Digital Twin to predict and prevent over 22,000 diseases and simulate personalized reactions on 750+ drugs
About
Industries
Biotechnology, Health Care, Medical, Genetics, Bioinformatics
Founded
2020
Employees
1-10
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Predictiv headquartered in United States, North America, operates in the Biotechnology, Health Care, Medical, Genetics, Bioinformatics sector. The company focuses on Biotechnology and has secured $66.0M in funding across 60 round(s). With a team of 1-10 employees, Predictiv is actively contributing to advancements in Biotechnology. Their latest funding round, Grant - Predictiv, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
3
Investors
1
Lead Investors
0
Total Funding Amount
$1.1M
Details
2
Predictiv has raised a total of $1.1M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2021 | Seed | 1.1M | ||
| 2022 | Seed |
Investors
Predictiv is funded by 10 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Erhan Bilici | - | FUNDING ROUND - Erhan Bilici | 1.1M |
| NAVER D2SF | - | FUNDING ROUND - NAVER D2SF | undefined |
| Predictiv | - | FUNDING ROUND - Predictiv | undefined |
| Health Engine | - | FUNDING ROUND - Health Engine | undefined |
Recent Activity
There is no recent news or activity for this profile.